Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease
AimsA strategy based on therapeutic drug monitoring and population pharmacokinetic (popPK) models would likely increase the rate of clinical remission (CR) after infliximab (IFX) induction in patients with Crohn's disease (CD). This study aimed to evaluate the relationship between early IFX lev...
保存先:
主要な著者: | , , , , , , , , , |
---|---|
フォーマット: | 図書 |
出版事項: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
インターネット
Connect to this object online.3rd Floor Main Library
請求記号: |
A1234.567 |
---|---|
所蔵 1 | 利用可 |